Potential Application of Oligonucleotide Therapeutics in SARS-CoV-2 Genomic RNA Knockdown

Masahito Inagaki
Additional contact information
Masahito Inagaki: Graduate School of Science, Nagoya University, Japan

Biomedical Journal of Scientific & Technical Research, 2023, vol. 53, issue 5, 45126-45133

Abstract: Oligonucleotide therapeutics have received a lot of attention that can target diverse molecules. Antisense oligonucleotides are one of the oligonucleotide therapeutics that control genetic information transmission by binding to target messenger RNA (mRNA) and non-coding RNA (ncRNA) with complementary sequences. Antisense oligonucleotides act intracellularly and can target molecules that cannot be targeted with antibody drugs, so they are expected to be the next generation of molecular targeting drugs.

Keywords: Journals on Medical Drug and Therapeutics; Journals on Emergency Medicine; Physical Medicine and Rehabilitation; Journals on Infectious Diseases Addiction Science and Clinical Pathology; Open Access Clinical and Medical Journal; Journals on Biomedical Science; List of Open Access Medical Journal; Journals on Biomedical Engineering; Open Access Medical Journal; Biomedical Science Articles; Journal of Scientific and Technical Research (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.008460.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.008460.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:53:y:2023:i:5:p:45126-45133

DOI: 10.26717/BJSTR.2023.53.008460

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().